Clinical Trial Update: Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma [Phase 2]

View source ↗

Summary

This clinical trial reports results from a Phase 2 study evaluating the safety and efficacy of a new chemotherapy agent for metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• New Chemotherapy Agent

Snippet

Sponsor: Bayer | Conditions: Melanoma | Phase 2 | Status: COMPLETED